Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Wilson Sonsini reports mandate on Circle Pharma’s $92.5 million Series E
Wilson Sonsini announced that it had advised Circle Pharma on a $92.5 million Series E led by The Column Group. The firm said the financing would support early clinical development of a breast-cancer treatment candidate and further development of the company’s pipeline of cyclin-targeted macrocycle drugs.
Key points
- The firm said Circle Pharma announced the financing on September 16.Wilson Sonsini Goodrich & Rosati
- Wilson Sonsini listed Nextech Invest, RA Capital Management, Euclidean Capital and Eli Lilly among the participants.Wilson Sonsini Goodrich & Rosati
- The firm identified the breast-cancer candidate as CID-165.Wilson Sonsini Goodrich & Rosati
- The announcement named Elton Satusky, Roy Argand, Davelyn Bulovas, Vincent Bai and Kathy Jordan on its team.Wilson Sonsini Goodrich & Rosati